Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WW and C2 domain containing 2 (WWC2) is a human protein that functions as a regulator of the Hippo signaling pathway, also known as the Salvador-Warts-Hippo (SWH) pathway[2][4]. WWC2 contains two N-terminal WW domains (which mediate binding to proteins with L/PPxY motifs), an internal C2 domain for membrane association, and several C-terminal motifs for protein-protein interactions[2]. WWC2 is able to form homo- and heterodimers and primarily acts as a scaffold protein, coordinating the phosphorylation and suppression of YAP1, a major effector of the Hippo pathway, thus negatively regulating cell proliferation and organ growth[2][4]. Dysfunction or altered expression of WWC2 has been associated with cancer, particularly as a tumor suppressor through regulation of proliferation signals, and diseases such as Long QT syndrome[2][7]. There are currently no known drugs that directly target WWC2.
not applicable (WWC2 is not a direct drug target; functions as a scaffold protein/adaptor, regulator of protein signaling pathways)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WW and C2 domain containing 2 (WWC2).